Cargando…

2177. Institutional Prevalence of Drug-Resistant Pathogens in Community-Acquired Pneumonia

BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of hospitalizations and plays a major role in mortality. The previous Infectious Diseases Society of America (IDSA) definition of healthcare-associated pneumonia (HCAP) was found to be neither sensitive nor specific for identifying dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Helen, Loomis, Jordan, Ortwine, Jessica, Mang, Norman S, Wei, Wenjing, Prokesch, Bonnie C, Shah, Nainesh, O'Connell, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752594/ http://dx.doi.org/10.1093/ofid/ofac492.1797

Ejemplares similares

1842. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Mang, Norman, et al.
Publicado: (2018)

1491. Standard- vs. High-dose Trimethoprim-Sulfamethoxazole for Stenotrophomonas maltophilia pneumonia
por: Hall, Brenton C, et al.
Publicado: (2020)

Cost-Savings Associated With Delayed Switch To Outpatient Antibiotic Regimen For Patients Requiring Daptomycin Therapy
por: Wei, Wenjing, et al.
Publicado: (2017)

218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
por: Wei, Wenjing, et al.
Publicado: (2018)

1459. Oral Cephalosporins vs. Fluoroquinolones for the Empiric Treatment of Acute Uncomplicated Pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2019)

2077. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Lin, Kevin, et al.
Publicado: (2019)

A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2022)

Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative
por: Lin, Kevin, et al.
Publicado: (2020)

1061. Decreased Utilization of Piperacillin–Tazobactam for Escherichia coli and Klebsiella Bacteremia due to Selective Susceptibility Reporting
por: Zahlanie, Yorgo, et al.
Publicado: (2019)

2177. Use of an Analytic Application for Management of Infection Prevention Data
por: Satchell, Lauren, et al.
Publicado: (2018)

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)

2177. Characterization of community-acquired methicillin-resistant Staphylococcus aureus isolated from patients with skin and soft tissue infections in selected health facilities, in Kenya
por: Njenga, John N
Publicado: (2023)

108. Evaluation of the Impact of Dalbavancin Usage on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital
por: Wei, Wenjing, et al.
Publicado: (2021)

Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital
por: Lueking, Richard, et al.
Publicado: (2022)

Functional Assessment of 2,177 U.S. and International Drugs Identifies the Quinoline Nitroxoline as a Potent Amoebicidal Agent against the Pathogen Balamuthia mandrillaris
por: Laurie, Matthew T., et al.
Publicado: (2018)

1347. Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics
por: Zahlanie, Yorgo, et al.
Publicado: (2020)

Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics
por: Zahlanie, Yorgo, et al.
Publicado: (2020)

PB2177: MULTICENTRE RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH MYELOFIBROSIS IN PIEDMONT. ROLE OF INFLAMMATION AND DYSIMMUNITY. MFACTORS STUDY.
por: Bonuomo, Valentina, et al.
Publicado: (2023)

1936. Implementation of IV Push Antibiotics for OPAT in a Safety Net Hospital Following a National Fluid Shortage
por: Bhavan, Kavita, et al.
Publicado: (2018)

PB2177: ANTITHYMOCYTE GLOBULIN AS TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE - 10 YEARS OF EXPERIENCE AT A SINGLE-CENTER
por: Dantas Rodrigues, C., et al.
Publicado: (2022)

PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA)
por: Aikawa, N, et al.
Publicado: (2013)

Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
por: Bae, Esther Y., et al.
Publicado: (2021)

Role of Atypical Pathogens in Nursing Home–Acquired Pneumonia
por: Ma, Hon Ming, et al.
Publicado: (2013)

2177. The Impact of the BioFire® FilmArray® Gastrointestinal Syndromic Panel on the Management of Infectious Gastroenteritis due to Diarrheagenic E. coli Strains in a Large Community Hospital
por: Jackson, Christoper Bryan, et al.
Publicado: (2019)

Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
por: Gadsby, Naomi J., et al.
Publicado: (2016)

Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia
por: Waterer, Grant W.
Publicado: (2017)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia
por: Wetzke, Martin, et al.
Publicado: (2023)

Enhanced Detection of Community-Acquired Pneumonia Pathogens With the BioFire® Pneumonia FilmArray® Panel
por: Gilbert, David N., et al.
Publicado: (2021)

Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia.
por: Marrie, T J, et al.
Publicado: (2001)

The prevalence of respiratory pathogens in adults with community-acquired pneumonia in an outpatient cohort
por: Chen, Jing, et al.
Publicado: (2019)

The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia
por: Gelfer, Gita, et al.
Publicado: (2015)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
por: Rubinstein, Ethan, et al.
Publicado: (2011)

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2018)

Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia: Prevalence, Pathogens, and Presentation
por: Johnstone, Jennie, et al.
Publicado: (2008)

Analysis of national surveillance of respiratory pathogens for community-acquired pneumonia in children and adolescents
por: Roh, Eui Jeong, et al.
Publicado: (2022)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_to851maehlhb36jcjemrt4tjve